D. et al. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation 104, 292–296 (2001). Article CAS PubMed Google Scholar Li, ...
UhmJS, MunHS, WiJ, ShimJ, HwangHJ, SungJH, et al. Importance of tachycardia cycle length for differentiating typical atrial flutter from scar-related in adult congenital heart disease. Pacing Clin Electrophysiol 2012;35:133847. AkarJG, KokLC, HainesDE, DiMarcoJP, MounseyJP. Coexistence of ...
technology should be the freedom from AF/atrial flutter/tachycardia off antiarrhythmic therapy of greater than 30 seconds’ duration. However, the acceptance that the burden of AF of less than 30 seconds is insignificant has no basis in scientific evidence, despite the need for an agreement for r...
Manhattan plots of genetic interactions with age, sex, body mass index, and hypertension in relation to AF risk. The red line shows the significant interaction p-value threshold (p < 4 × 10−8), and the blue line shows the suggestive significant interaction p-value threshold (p...
Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease. Atherosclerosis 2014, 232, 224–230. [CrossRef] [PubMed] 44. Lin, L.J.; Cheng, M.H.; Lee, C.H.; Wung, D.C.; Cheng, C.L.; Kao Yang, Y.H. ...